Driehaus Capital Management LLC Xenon Pharmaceuticals Inc. Transaction History
Driehaus Capital Management LLC
- $10.3 Billion
- Q2 2025
A detailed history of Driehaus Capital Management LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 4,335,648 shares of XENE stock, worth $159 Million. This represents 1.31% of its overall portfolio holdings.
Number of Shares
4,335,648
Previous 4,584,859
5.44%
Holding current value
$159 Million
Previous $154 Million
11.78%
% of portfolio
1.31%
Previous 1.68%
Shares
22 transactions
Others Institutions Holding XENE
# of Institutions
221Shares Held
73.2MCall Options Held
336KPut Options Held
309K-
Avoro Capital Advisors LLC New York, NY5.4MShares$198 Million3.08% of portfolio
-
Braidwell LP Stamford, CT3.61MShares$132 Million6.91% of portfolio
-
Janus Henderson Group PLC London, X03.58MShares$131 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.18MShares$117 Million0.02% of portfolio
-
Commodore Capital LP New York, NY3.03MShares$111 Million8.83% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.29B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...